TREATMENT OF EXTRANODAL NK/T‐CELL LYMPHOMA, NASAL TYPE (ENKTL)
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2437_112
Abstract: ease outcome, the prognosis of NKTCL is generally poor, and no targeted therapy is currently available. Recent studies indicated that L‐ASP‐based regimen, such as SMILE, AspMetDex and P‐GEMOX regimen were efficient in treating NKTCL. Using… read more here.
Keywords: treatment extranodal; extranodal cell; lymphoma nasal; nasal type ... See more keywords